{
    "ticker": "HLLY",
    "name": "Helius Medical Technologies, Inc.",
    "description": "Helius Medical Technologies, Inc. is a medical technology company focused on developing and commercializing non-invasive products for the treatment of neurological diseases and conditions. The company is dedicated to creating innovative solutions that enhance the quality of life for individuals suffering from serious neurological disorders. Helius is primarily known for its flagship product, the Portable Neuromodulation Stimulator (PoNS\u2122), which is designed to treat balance deficits due to mild to moderate traumatic brain injury (TBI) and other neurological impairments. By employing neuromodulation technology, PoNS\u2122 works to stimulate the brain and promote recovery by enhancing neuroplasticity. Helius is committed to rigorous clinical research and has been involved in multiple clinical trials to validate the efficacy and safety of its products. The company aims to expand its product offerings and further its mission of improving patient outcomes through advanced medical technology. With a growing portfolio of intellectual property and ongoing collaborations with leading research institutions, Helius is poised to make significant contributions to the field of neurology and establish itself as a leader in the medical device industry.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Newtown, Pennsylvania, USA",
    "founded": "2014",
    "website": "https://www.heliusmedical.com",
    "ceo": "Philippe Deschamps",
    "social_media": {
        "twitter": "https://twitter.com/HeliusMed",
        "linkedin": "https://www.linkedin.com/company/helius-medical-technologies/"
    },
    "investor_relations": "https://investors.heliusmedical.com",
    "key_executives": [
        {
            "name": "Philippe Deschamps",
            "position": "CEO"
        },
        {
            "name": "Dawn McGuire",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Neuromodulation Devices",
            "products": [
                "Portable Neuromodulation Stimulator (PoNS\u2122)"
            ]
        }
    ],
    "seo": {
        "meta_title": "Helius Medical Technologies, Inc. | Neuromodulation Solutions for Neurological Disorders",
        "meta_description": "Explore Helius Medical Technologies, Inc., a leader in developing innovative neuromodulation devices for treating neurological conditions. Discover our commitment to improving patient lives.",
        "keywords": [
            "Helius Medical",
            "Neuromodulation",
            "Portable Neuromodulation Stimulator",
            "TBI Treatment",
            "Healthcare Technology"
        ]
    },
    "faq": [
        {
            "question": "What is Helius Medical Technologies known for?",
            "answer": "Helius Medical Technologies is known for developing non-invasive neuromodulation products, particularly the Portable Neuromodulation Stimulator (PoNS\u2122)."
        },
        {
            "question": "Who is the CEO of Helius Medical Technologies?",
            "answer": "Philippe Deschamps is the CEO of Helius Medical Technologies, Inc."
        },
        {
            "question": "Where is Helius Medical headquartered?",
            "answer": "Helius Medical is headquartered in Newtown, Pennsylvania, USA."
        },
        {
            "question": "What is the main product of Helius Medical?",
            "answer": "Helius Medical's main product is the Portable Neuromodulation Stimulator (PoNS\u2122), designed to treat balance deficits due to TBI."
        },
        {
            "question": "When was Helius Medical founded?",
            "answer": "Helius Medical was founded in 2014."
        }
    ],
    "competitors": [
        "NVCR",
        "IRBT",
        "AXNX"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "ZTS",
        "BMY"
    ]
}